NeuroOne Medical Technologies CorporationNMTCNASDAQ
Loading
Year-over-year operating income growth rate
Latest
-24.52%
↑ 91% vs avg
Percentile
P31
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
-287.68%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -24.52% |
| Q3 2025 | 27.33% |
| Q2 2025 | 29.60% |
| Q1 2025 | -256.62% |
| Q4 2024 | 160.75% |
| Q3 2024 | -0.82% |
| Q2 2024 | 3.19% |
| Q1 2024 | 14.88% |
| Q4 2023 | -7.13% |
| Q3 2023 | 9.84% |
| Q2 2023 | -0.41% |
| Q1 2023 | -95.92% |
| Q4 2022 | -27.44% |
| Q3 2022 | 49.29% |
| Q2 2022 | 9.75% |
| Q1 2022 | -8.92% |
| Q4 2021 | -6.25% |
| Q3 2021 | 12.88% |
| Q2 2021 | -26.69% |
| Q1 2021 | -11.77% |
| Q4 2020 | -1725.34% |
| Q3 2020 | 92.63% |
| Q2 2020 | -15.69% |
| Q1 2020 | 24.07% |
| Q4 2019 | -34.02% |
| Q3 2019 | 27.35% |
| Q2 2019 | -22.47% |
| Q1 2019 | -41.39% |
| Q4 2018 | 4.14% |
| Q3 2018 | 4.26% |
| Q2 2018 | -6.81% |
| Q1 2018 | 19.58% |
| Q4 2017 | -52.69% |
| Q3 2017 | -0.57% |
| Q2 2017 | -72.21% |
| Q1 2017 | -182.51% |
| Q4 2016 | -9310.97% |
| Q3 2016 | 86.24% |
| Q2 2016 | -221.66% |
| Q1 2016 | 69.89% |